MANNITOL
As listed in the register: MANNITOL 10 % AGUETTANT, solution pour perfusion
10 g · solution pour perfusion
- Prescription status not stated
- Active substance
- Mannitol
- Made by
- AGUETTANT
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Aridol Bronchial Challenge Test Kit). It describes the substance, not this exact product.
The precise mechanisms through which inhaled mannitol causes bronchoconstriction are not known.
Following inhalation of 635 mg of mannitol in 18 healthy subjects, about 55% of the total dose was excreted in the urine as unchanged mannitol.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-04-23
Safety of the active substance
From the US prescribing label for the same active substance (Aridol Bronchial Challenge Test Kit). It describes the substance, not this exact product.
WARNING: RISK OF SEVERE BRONCHOSPASM Mannitol, the active ingredient in ARIDOL, acts as a bronchoconstrictor and may cause severe bronchospasm.
- ARIDOL is contraindicated in: Patients with known hypersensitivity to mannitol or to the gelatin used to make the capsules Patients with conditions that may be compromised by induced bronchospasm or repeated spirometry maneuvers.
- Some examples include: aortic or cerebral aneurysm, uncontrolled hypertension, recent myocardial infarction or cerebral vascular accident [ see Warnings and Precautions ( 5.2 )].
- Known hypersensitivity to mannitol or to the gelatin used to make the capsules ( 4 ) Conditions that may be compromised by induced bronchospasm or repeated spirometry maneuvers ( 4 )
Most common adverse reactions (rate ≥1%) were headache, pharyngolaryngeal pain, throat irritation, nausea, cough, rhinorrhea, dyspnea, chest discomfort, wheezing, retching and dizziness.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | AGUETTANT |
|---|---|
| Active substance | Mannitol |
| Strength | 10 g |
| Form | solution pour perfusion |
| Route | intraveineuse |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | MANNITOL 10 % AGUETTANT, solution pour perfusion |
| Packs | 1 poche(s) PVC plastifié suremballée(s)/surpochée(s) de 500 ml |
| CIS | 62126714 |
| CIP13 | 3400935516114 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.